Products for Research Use Only

Amcinonide (Standard)

CAT: 0804-HY-B1197RSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B1197RSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Amcinonide (Standard) is the analytical standard of Amcinonide. This product is intended for research and analytical applications. Amcinonide is an inhibitor of NO release (IC50 = 3.38 nM) . Amcinonide inhibits NNC-induced expression of the proinflammatory genes iNOS, TNF-α, and IL-1β in glial cells. Amcinonide reduces the numbers of T6+/Ia+ cells with a concomitant increase in T6+/Ia- cells. Amcinonide induces a selective reduction in expression of Ia antigens. Amcinonide can also be studied in research for eczematous dermatitis[1][2][3].
CAS Number
51022-69-6
Product Name Alternative
CL-34699 (Standard)
UNSPSC
12352005
Target
Glucocorticoid Receptor; Interleukin Related; NO Synthase; Reference Standards; TNF Receptor
Type
Reference Standards
Related Pathways
Apoptosis; Immunology/Inflammation; Others; Vitamin D Related/Nuclear Receptor
Field of Research
Inflammation/Immunology; Endocrinology
Assay Protocol
https://www.medchemexpress.com/amcinonide-standard.html
Smiles
C[C@@]12[C@@]3(C(COC(C)=O)=O)[C@@](OC4(O3)CCCC4)([H])C[C@@]1([H])[C@]5([H])CCC6=CC(C=C[C@]6(C)[C@@]5(F)[C@@H](O)C2)=O
Molecular Formula
C28H35FO7
Molecular Weight
502.57
References & Citations
[1]Hong J, et al. Identification and characterization of triamcinolone acetonide, a microglial-activation inhibitor. Immunopharmacol Immunotoxicol. 2012 Dec;34 (6) :912-918.|[2]Berman B, et al. Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids. J Invest Dermatol. 1983 Mar;80 (3) :168-171.|[3]Bickers D. R. (1984) . A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis. Cutis, 34 (2), 190–194.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards